{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/cough-acute-with-chest-signs-in-children/prescribing-information/amoxicillin-co-amoxiclav/","result":{"pageContext":{"chapter":{"id":"f1a05b5b-c5fe-5138-a544-4d447c78a07e","slug":"amoxicillin-co-amoxiclav","fullItemName":"Amoxicillin and co-amoxiclav","depth":2,"htmlHeader":"","summary":"","htmlStringContent":"<!-- begin item ad7f2046-f831-4775-b047-a70100f56f4e --><!-- begin field 0fcf7bcb-f26c-43eb-850e-a70100f573c0 --><h2 _ngcontent-kyl-9=\"\">Amoxicillin and co-amoxiclav</h2><!-- end field 0fcf7bcb-f26c-43eb-850e-a70100f573c0 --><!-- end item ad7f2046-f831-4775-b047-a70100f56f4e -->","topic":{"id":"ecc57759-d8a2-50b5-addc-68127dd57e13","topicId":"6f239a86-8a9f-4fc1-85b2-df045fbf9477","topicName":"Cough - acute with chest signs in children","slug":"cough-acute-with-chest-signs-in-children","lastRevised":"Last revised in January 2021","chapters":[{"id":"82620eeb-35c8-583d-957c-c8c9d68f0bc4","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"85e154c6-7444-55c1-8105-4238c565d6d6","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"34d842b6-5846-5142-96f5-6451b7b9503f","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"94ebcc3a-8e44-5c7a-84a1-44c122e86fc5","slug":"changes","fullItemName":"Changes"},{"id":"19991281-8b30-5f16-8552-ba71a6c2257f","slug":"update","fullItemName":"Update"}]},{"id":"31245ad9-f63e-5053-8f0f-9e310f133212","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"b1846e94-64be-5a1d-b26e-9bc518192b43","slug":"goals","fullItemName":"Goals"},{"id":"52d51fe3-1e3c-5479-82e5-628353de2bda","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"59199121-d653-59c9-a7ff-03835d711500","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"73cf3120-d25a-5284-8593-e93c81d39c8d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"4f7d288f-bf0c-5dd9-aad8-54ef82e7e039","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"60fdd9e2-e6fd-5e5b-98d4-33afb2271bf6","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"40cbe9e5-667a-56f8-9039-e094f48e40da","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"b9756443-edc1-5707-af00-970491b93f52","slug":"definition","fullItemName":"Definition"},{"id":"ef20d952-44e6-5372-8021-cb07f3444dc1","slug":"prevalence","fullItemName":"Prevalence"},{"id":"39f5f767-cf1c-554f-ac8c-1c89c7b73a53","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"eee4bb33-4743-5ff3-b4e0-221f6f6670c7","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"476813be-e2a1-5849-b379-e674dda72f03","slug":"diagnosis-of-cause","fullItemName":"Diagnosis of cause"},{"id":"b9d5f16f-3395-562d-a46b-b1f06bd6bed5","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"899fa269-48ce-5ff0-82b9-83b8bbd23fd5","fullItemName":"Management","slug":"management","subChapters":[{"id":"a34c98a9-afaf-51ce-9449-23569af98723","slug":"viral-induced-wheeze-possible-asthma","fullItemName":"Scenario: Viral-induced wheeze/possible asthma"},{"id":"87edfa6f-d156-5750-9778-a82799c16245","slug":"bronchiolitis","fullItemName":"Scenario: Bronchiolitis"},{"id":"aa61e13e-692a-56aa-a17b-a9429aa076d0","slug":"community-acquired-pneumonia","fullItemName":"Scenario: Community-acquired pneumonia"}]},{"id":"e3645b31-0302-5b3c-ad3d-fad31e7f02f9","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"f1a05b5b-c5fe-5138-a544-4d447c78a07e","slug":"amoxicillin-co-amoxiclav","fullItemName":"Amoxicillin and co-amoxiclav"},{"id":"82dc91ea-2a15-5ea8-979f-6ff8f0d34a7a","slug":"cefaclor","fullItemName":"Cefaclor"},{"id":"64d06ec1-7d56-574c-a9cc-ee35cfd204e4","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"20c13e81-9ef3-5df6-9f51-eb0dfacaaeab","slug":"ibuprofen-paracetamol","fullItemName":"Ibuprofen and paracetamol"},{"id":"87a5f8d7-3f8e-5b8e-81b4-364a14a73467","slug":"macrolides","fullItemName":"Macrolides"},{"id":"0697a2ca-e9c2-512d-ab11-d573f39abddf","slug":"prednisolone","fullItemName":"Prednisolone"},{"id":"f40afbec-15db-5ba5-8bf8-b4ddeee5aeec","slug":"short-acting-beta-2-agonists","fullItemName":"Short-acting beta-2 agonists"}]},{"id":"91f18501-a585-5063-808d-45ce72bc128b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"87a7a774-5455-587b-b324-53fd94fb5173","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0ddbcc1e-d9b8-5a7f-becd-f71b188dbbd0","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"d35bce52-adec-5cb7-9ea1-acf95169edd6","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"a68992e4-ba15-5c95-9370-e987b9a61f0e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"610e5926-a430-5217-a4dc-6de7f4a3d7c8","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"d9335bd0-caf6-5162-a6c3-4efb35bf6011","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"b3e96fe7-7269-59f4-8328-c9710f4dbc76","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"e3645b31-0302-5b3c-ad3d-fad31e7f02f9","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"52fda8a9-aab9-5651-a5df-aff060a994aa","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 45c5c891-ad95-4dde-8a03-a70100f8c2c5 --><h3>Contraindications and cautions</h3><!-- end field 45c5c891-ad95-4dde-8a03-a70100f8c2c5 -->","summary":"","htmlStringContent":"<!-- begin item 923ddaff-9780-42fa-864a-a70100f8bff2 --><!-- begin field 78ef8b1c-a528-49e1-8d79-a70100f8c2c5 --><ul><li><strong>Do not prescribe amoxicillin or co-amoxiclav</strong> <strong>to people with:</strong><ul><li>History of penicillin-associated hepatic dysfunction.</li><li>A <em>true</em> penicillin hypersensitivity. Gastrointestinal adverse effects alone (such as nausea, vomiting, or diarrhoea) do <em>not</em> constitute an allergy to penicillin.</li></ul></li><li><strong>Prescribe amoxicillin or co-amoxiclav with caution</strong> <strong>to people with:</strong><ul><li>Hypersensitivity to cephalosporins.</li><li>Chronic kidney disease (CKD) — reduce the dose if the estimated glomerular filtration rate (eGFR) is less than 10 mL/min/1.73 m<sup>2</sup>.</li><li>Co-amoxiclav should also be prescribed with caution to people with hepatic impairment.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">Micromedex, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">ABPI Medicines Compendium, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">ABPI Medicines Compendium, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">BNF 72, 2016</a>]</p><!-- end field 78ef8b1c-a528-49e1-8d79-a70100f8c2c5 --><!-- end item 923ddaff-9780-42fa-864a-a70100f8bff2 -->","subChapters":[]},{"id":"415eb257-6f71-565a-8686-9bbe9afd9f76","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field ad728c81-d84d-4712-b424-a70100f8db9d --><h3>Adverse effects</h3><!-- end field ad728c81-d84d-4712-b424-a70100f8db9d -->","summary":"","htmlStringContent":"<!-- begin item dd46ef24-b723-4177-9bdd-a70100f8d83c --><!-- begin field b39019ed-837d-4df5-b6fe-a70100f8db9d --><ul><li><strong>The most common adverse effects of amoxicillin and co-amoxiclav include</strong> nausea, vomiting, skin rash, and diarrhoea.</li><li><strong>Consider pseudomembranous colitis</strong> if a person develops severe diarrhoea during or after treatment with amoxicillin or co-amoxiclav.<ul><li>Pseudomembranous colitis is an acute, exudative colitis caused by <em>Clostridium difficile</em>, a Gram-positive toxin-releasing bacillus. It often follows antibiotic treatment. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/diarrhoea-antibiotic-associated/\">Diarrhoea - antibiotic associated</a>.</li></ul></li><li><strong>Amoxicillin and co-amoxiclav</strong> can also cause fungal infection and vaginitis.</li><li><strong>Anaphylaxis (delayed or immediate)</strong> is a serious but rare adverse effect of treatment with amoxicillin and co-amoxiclav. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a>.</li><li><strong>Hepatitis and cholestatic jaundice</strong> may rarely occur following treatment with co-amoxiclav.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">Micromedex, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">ABPI Medicines Compendium, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">ABPI Medicines Compendium, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">BNF 72, 2016</a>]</p><!-- end field b39019ed-837d-4df5-b6fe-a70100f8db9d --><!-- end item dd46ef24-b723-4177-9bdd-a70100f8d83c -->","subChapters":[]},{"id":"1989d1de-a225-56d5-9ca2-2bdd86a8d018","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field ff9dbc52-3bd8-463e-9bc0-a70100f8fa62 --><h3>Drug interactions</h3><!-- end field ff9dbc52-3bd8-463e-9bc0-a70100f8fa62 -->","summary":"","htmlStringContent":"<!-- begin item c426c25d-946b-4c06-9884-a70100f8f436 --><!-- begin field 36677e96-53e6-49a4-b485-a70100f8fa62 --><p><strong>Possible drug interactions with amoxicillin and co-amoxiclav include:</strong></p><ul><li><strong>Allopurinol</strong> — be aware of the increased risk of rash when allopurinol is given with amoxicillin or co-amoxiclav. It is not necessary to stop either drug if this occurs.</li><li><strong>Warfarin</strong> — monitor the international normalized ratio (INR) closely during concomitant use. Any significant changes seem to occur after 4 days of concurrent use. Adjust the warfarin dose as necessary according to the INR.</li><li><strong>Methotrexate</strong> — consider measuring platelet and white cell counts twice weekly for 2 weeks initially, and measure methotrexate levels if toxicity is suspected.</li></ul><div><div>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">Baxter, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">ABPI Medicines Compendium, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">ABPI Medicines Compendium, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">BNF 72, 2016</a>]</div></div><!-- end field 36677e96-53e6-49a4-b485-a70100f8fa62 --><!-- end item c426c25d-946b-4c06-9884-a70100f8f436 -->","subChapters":[]},{"id":"e4d31f7a-c2b6-5116-b707-67f5f838db00","slug":"dosing-information","fullItemName":"Dosing information","depth":3,"htmlHeader":"<!-- begin field 68f90781-0139-4589-804e-a70100f91657 --><h3>Dosing information</h3><!-- end field 68f90781-0139-4589-804e-a70100f91657 -->","summary":"","htmlStringContent":"<!-- begin item 7c85c06d-02c2-43d3-b94c-a70100f91033 --><!-- begin field 3f7699fc-46d3-4215-9174-a70100f91657 --><ul><li>Amoxicillin:<ul><li>Age 0 to 28 days – 30 mg/kg (max. 125 mg) 3 times daily.</li><li>Age 1 month to 1 year – 125 mg 3 times daily; increased if necessary up to 30 mg/kg 3 times daily.</li><li>Age 1 to 5 years – 250 mg 3 times daily; increased if necessary up to 30 mg/kg 3 times daily.</li><li>Age 5 to 12 years – 500 mg 3 times daily; increased if necessary up to 30 mg/kg (max. 1 g) 3 times daily.</li><li>Age 12 to 16 years – 500 mg 3 times daily; in severe infection 1 g 3 times daily.</li></ul></li><li>Co-amoxiclav:<ul><li>Age 1 month to 1 year – 0.25 mL/kg of 125/31 suspension every 8 hours, dose doubled in severe infection.</li><li>Age 1 to 6 years – 5 mL of 125/31 suspension every 8 hours or 0.25 mL/kg of 125/31 suspension every 8 hours, dose doubled in severe infection.</li><li>Age 6 to 12 years – 5 mL of 250/62 suspension every 8 hours or 0.15 mL/kg of 250/62 suspension every 8 hours, dose doubled in severe infection.</li><li>Age 12 to 16 years – one 250/125 mg strength tablet every 8 hours.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/references/\">BNF 72, 2016</a>]</p><!-- end field 3f7699fc-46d3-4215-9174-a70100f91657 --><!-- end item 7c85c06d-02c2-43d3-b94c-a70100f91033 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}